← Leaderboards
Bruce G Brown
University Of Washington
$5,814,431
Attributed
$5,814,431
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–09$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$5,814,431 · 2
By mechanism
U01$5,488,809 · 1
R01$325,622 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Jay W Heinecke$34,087,651
- Karin E. Bornfeldt$36,322,585
- Alan Chait$20,398,633
- Tomas Vaisar$10,474,916
- John F Oram$8,126,326
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisHigh Density LipoproteinsAcute Coronary SyndromeApolipoproteins AApolipoproteins BApolipoproteins CClinical Trials DesignCardiovascular Risk FactorCause Of DeathBlood GlucoseBlood VesselsBrain HemorrhageCanadaCardiovascular DiseasesApoproteinsClinical TrialsCardiovascular SystemAdultCombined Modality TherapyCentral ObesityCerebrovascularCessation Of LifeCholesterolControlled Clinical Trials
Grant awards (6)
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events$755,625
U01 · FY2009 · HL · contact PI
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events$963,754
U01 · FY2008 · HL · contact PI
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events$1,481,774
U01 · FY2007 · HL · contact PI
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events$1,624,281
U01 · FY2006 · HL · contact PI
AIM HIGH: Niacin Plus Statin to Prevent Vascular Events$663,375
U01 · FY2005 · HL
DOES ATHEROSCLEROSIS REGRESS WITH THERAPY FOR LOW HDLC?$325,622
R01 · FY2000 · HL